ONCOSOMIX
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

ONCOSOMIX Trademark

Serial Number: 79383408 • Registration: 7756813

ONCOSOMIX is a trademark filed by LINKCARE HEALTH SERVICES, S.L. on October 13, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

LINKCARE HEALTH SERVICES, S.L. (3 trademarks)

ROGER DE LLURIA, 50, SOBREATICO A

Entity Type: 99

Trademark Details

Filing Date

October 13, 2023

Registration Date

April 15, 2025

Published for Opposition

February 25, 2025

Goods & Services

Preparations for cleansing the skin for medical use; biological preparations for use in cell cultures for medical purposes; chemical preparations for medical use, namely, for the treatment and detection of cancer; chemico-pharmaceutical preparations for the treatment and detection of cancer; diagnostic preparations for medical use; chemical reagents for medical or veterinary use; diagnostic reagents for medical use; reagents for clinical diagnosis for medical use; reagents for clinical analyses for medical use; reagents with biomarkers for medical diagnostics; immunoassay reagents for medical use; diagnostic testing materials for medical use, namely, diagnostic test reagents for medical use

Medical apparatus and instruments, namely, in vitro diagnostic devices for the screening, detection, evolution and treatment response of diseases based in the analysis of biomarkers in neuron-derived extracellular vesicles; diagnostic apparatus for medical use, namely, medical diagnostic apparatus for testing in vitro diagnostic devices for the screening, detection, evolution and treatment response monitoring of cancer diseases based in the analysis of biomarkers in cancer-derived extracellular vesicles; detector apparatus for medical use in diagnosis namely, medical diagnostic apparatus for testing in vitro diagnostic devices for the screening, detection, evolution and treatment response monitoring of cancer diseases based in the analysis of biomarkers in cancer-derived extracellular vesicles; apparatus for diagnostic testing for medical purpose for the detection of cancer; medical equipment for diagnosis, examination and monitoring in the nature of respiratory equipment and monitors therefor; tools for medical diagnosis, namely, medical device and surgical instrument for use in diagnosis and surgery of the gastro-intestinal tract; medical diagnostic instruments for the analysis of body fluids; testing instruments for medical diagnostic use in the nature of ultrasonic medical diagnostic apparatus; medical diagnostic testing instruments for use in immunoassay procedures in the nature of immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; immunological analyzers in the nature of immunochemical testing apparatus for medical use

Chemical preparations for analysis in laboratories, other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purposes; diagnostic preparations and reagents, other than for medical or veterinary use; chemical diagnostic preparations for scientific purposes; diagnostic scanning agents for scientific use in vivo; diagnostic preparations for clinical diagnostic use, other than for medical or veterinary use; diagnostic kits comprising specimen receptors antibody-like synthetic bioreceptors for detection of oncology-related biomarkers and reagents for analyzing selected bacteria, other than for medical or veterinary use; diagnostic testing materials, other than for medical use, namely, diagnostic preparations for in vitro testing for scientific use; chemical preparations for use in immunoassay testing other than for medical or veterinary use; immunoassay reagents, other than for medical and veterinary use

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 15, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 28, 2025 FICS
FINAL DISPOSITION PROCESSED
Oct 28, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 15, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 3, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 16, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 16, 2025 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 15, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 15, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 25, 2025 NPUB
PUBLISHED FOR OPPOSITION
Feb 25, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 19, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 5, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 27, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 27, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 27, 2024 TROA
REFUSAL PROCESSED BY IB
Jul 20, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 28, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jun 28, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 15, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jun 8, 2024 CNRT
ASSIGNED TO EXAMINER
May 31, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 21, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 17, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 16, 2023 REPR